Business Description
Stayble Therapeutics AB
ISIN : SE0013513652
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -30.7 | |||||
3-Year EPS without NRI Growth Rate | -27.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.28 | |||||
9-Day RSI | 39.45 | |||||
14-Day RSI | 42.1 | |||||
6-1 Month Momentum % | 333.11 | |||||
12-1 Month Momentum % | -84.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.74 | |||||
Quick Ratio | 3.74 | |||||
Cash Ratio | 2.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.9 | |||||
Shareholder Yield % | -9.27 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -48.47 | |||||
ROA % | -39.82 | |||||
ROIC % | -126.31 | |||||
ROCE % | -45.25 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.64 | |||||
Price-to-Tangible-Book | 4.19 | |||||
EV-to-EBIT | -1.98 | |||||
EV-to-EBITDA | -1.98 | |||||
EV-to-FCF | -4.12 | |||||
Price-to-Net-Current-Asset-Value | 4.19 | |||||
Price-to-Net-Cash | 4.19 | |||||
Earnings Yield (Greenblatt) % | -50.42 | |||||
FCF Yield % | -20.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Stayble Therapeutics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.029 | ||
Beta | 0 | ||
Volatility % | 229.28 | ||
14-Day RSI | 42.1 | ||
14-Day ATR (€) | 0.006998 | ||
20-Day SMA (€) | 0.048835 | ||
12-1 Month Momentum % | -84.95 | ||
52-Week Range (€) | 0.008 - 0.493 | ||
Shares Outstanding (Mil) | 43.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Stayble Therapeutics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Stayble Therapeutics AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Stayble Therapeutics AB Frequently Asked Questions
What is Stayble Therapeutics AB(STU:4K4)'s stock price today?
When is next earnings date of Stayble Therapeutics AB(STU:4K4)?
Does Stayble Therapeutics AB(STU:4K4) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |